Management of Osteoporosis in the Era of COVID-19

Osteoporosis is a chronic illness characterised by weakened bones and an increased risk of fracture. Osteoporosis is a chronic disorder that usually need long-term medical treatment to prevent further bone loss, skeletal integrity damage, and fractures. The fact that rapid termination of some medications is linked to an elevated risk of injury further complicates the situation. In this setting, the COVID-19 pandemic has caused extraordinary disruption in the delivery of health care throughout the world, including near-universal social distancing restrictions. In this Perspective, we present information on the general management of osteoporosis patients in the COVID-19 period, when available, and clinical recommendations based mostly on expert opinion when data are lacking. The transition from parenteral osteoporosis treatments is given special attention. These suggestions are envisaged to be used to safely guide care for osteoporosis patients until a restoration to normal clinical care standards is possible.

 

    Related Conference of Management of Osteoporosis in the Era of COVID-19

    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 18-19, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 18-19, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 26-27, 2024

    33rd International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Paris, France
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    January 27-28, 2025

    29th International Conference on Diabetes, Endocrinology and Healthcare

    Dubai, UAE
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    February 24-25, 2025

    20th International Conference on Endocrinology and Metabolic Disorders

    London, UK
    March 10-11, 2025

    18th European Diabetes and Endocrinology Congress

    Rome, Italy
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    19th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    March 24-25, 2025

    6th Global summit on Diabetes and Endocrinology

    London, UK
    April 07-08, 2025

    36th International Congress on Prevention of Diabetes and Complications

    Vancouver, Canada
    April 10-11, 2025

    31st International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

    Dubai, UAE
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    27th World Congress on Diabetes and Endocrine Disorders

    Dubai, UAE
    May 05-06, 2025

    24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Rome, Italy
    May 12-13, 2025

    2nd International Congress on Endocrinology and Complications of Diabetes

    Rome, Italy
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    June 24-25, 2025

    23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France

    Management of Osteoporosis in the Era of COVID-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in